Background: Despite the growing number and proportion of the immigrant population in the US, there is a lack of knowledge on healthcare expenditures among immigrants with cognitive limitations or Alzheimer's disease and related dementias (ADRD). This study estimated differences in total healthcare expenditures between US-born and foreign-born individuals by the presence of ADRD and/or cognitive limitations. This study also examined the differences in healthcare expenditures by service types, including inpatient stays, office-based visits, emergency department (ED) visits, home healthcare, and prescription drugs.
Method: The study used nationally representative data from the 2007-2020 Medical Expenditure Panel Survey (MEPS). Generalized linear regression models were used to estimate differences in healthcare expenditures between US-born and foreign-born individuals with ADRD, cognitive limitations without ADRD, and without ADRD or cognitive limitations. Analyses were also implemented by the immigrants' duration of residence in the US, classified as foreign-born living less than 10 years in the US and more than 10 years in the US. The study sample included all community-dwelling adult Americans and had separate subpopulation analyses on the elderly population aged 65 and above. Survey weights were applied to all estimates.
Result: Foreign-born individuals with cognitive limitations or ADRD had substantially higher total healthcare expenditures than their counterparts. Compared to US-born individuals with ADRD, foreign-born individuals with ADRD spent significantly more on home healthcare ($4,456.1, p = 0.029). Among individuals without ADRD or cognitive limitations, foreign-born individuals spent significantly less than their US-born counterparts in most healthcare services. Compared to their US-born counterparts, immigrants with ADRD who had lived in the US for more than 10 years encountered significantly higher home healthcare costs ($4,245.6, p = 0.031), whereas those who had lived in the US for less than 10 years incurred significantly lower costs on office-based visits (-$1,833.8, p<0.001) and ED visits (-$514.4, p<0.001). In contrast, immigrants with no ADRD and cognitive limitations spent significantly less than their US-born counterparts on healthcare regardless of residence duration in the US.
Conclusion: Foreign-born individuals with cognitive limitations or ADRD had substantially higher total healthcare expenditures than their US-born counterparts, while foreign-born individuals without ADRD or cognitive limitations spent significantly less than their US-born counterparts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.088801 | DOI Listing |
Aust Occup Ther J
February 2025
Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia.
Introduction: Driving safety may be compromised in people with dementia or mild cognitive impairment (MCI). Occupational therapists assess and screen for driving safety in older people with cognitive impairment. However, little is known about their perspectives relating to these assessments.
View Article and Find Full Text PDFJ Cogn Psychother
January 2025
Faculty of Letters, Departments of Atatürk, Atatürk University, Erzurum, Turkey.
This study was conducted to test the reliability and validity of the Pathogenic Belief Scale (PBS) on adult individuals. Participants consisted of 299 adults, including 189 (63.2%) females and 110 (36.
View Article and Find Full Text PDFBrain Res Bull
January 2025
Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China.
Alzheimer's disease (AD) stands as one of the most prevalent neurodegenerative disorders, characterized by a progressive decline in cognitive function, neuroinflammation, amyloid-beta (Aβ) plaques, and neurofibrillary tangles (NFTs). With the global aging population, the incidence of AD continues to rise, yet current therapeutic strategies remain limited in their ability to significantly alleviate cognitive impairments. Therefore, a deeper understanding of the molecular mechanisms underlying AD is imperative for the development of more effective treatments.
View Article and Find Full Text PDFBehav Brain Res
January 2025
College of Electronic & Information Engineering, Hebei University, Baoding, China.
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with an unclear pathogenesis to date. Neurofeedback (NFB) had shown therapeutic effects in patients with ASD. In this study,we analyzed the brain functional networks of children with ASD and investigated the impact of NFB targeting the beta rhythm training on these networks.
View Article and Find Full Text PDFNeurobiol Dis
January 2025
Institute of Physiology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address:
Background: Fabry disease (FD) patients are known to be at high risk of developing neuropsychiatric symptoms such as anxiety, depression and cognitive deficits. Despite this, they are underdiagnosed and inadequately treated. It is unknown whether these symptoms arise from pathological glycosphingolipid deposits or from cerebrovascular abnormalities affecting neuronal functions in the central nervous system.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!